Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
Ellen Copson(University of Southampton), William Tapper(University of Southampton), Alastair M. Thompson(Baylor College of Medicine), Alison M. Dunning(University of Cambridge), Douglas G. Altman(Unknown), Sunil R. Lakhani(Sullivan Nicolaides Pathology), Douglas F. Easton(University of Cambridge), Lorraine Durcan(University of Southampton), Tom Maishman(University of Southampton), Fiona J. Gilbert(University of Cambridge), Ramsey Cutress(University of Southampton), Peter Simmonds(University of Turku), J. Louise Jones(Queen Mary University of London), Bryony Eccles(University of Southampton), Louise Stanton(University of Southampton), D. Gareth Evans(Manchester Academic Health Science Centre), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Stephanie Greville‐Heygate(University Hospital Southampton NHS Foundation Trust), Shirley Hodgson(St Thomas' Hospital), Hisham Hamed(St Thomas' Hospital), Andrew M. Hanby(University of Leeds), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Sue Gerty(University of Southampton)
Cited by 501
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
International evaluation of an AI system for breast cancer screening
|Nature|2020|3.1k
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
|European Journal of Epidemiology|2016|3.1k
Evaluating non-randomised intervention studies
|Health Technology Assessment|2003|2.9k